ArticleJournal of clinical medicine2025

Tyrosine Kinase Inhibitor Therapy Enhances Stem Cells Profile and May Contribute to Survival of Chronic Myeloid Leukemiastem Cells.

Simone Rocco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.